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Cyclin A2 degradation during the spindle assembly
checkpoint requires multiple binding modes to the
APC/C
Suyang Zhang1,2, Thomas Tischer 1 & David Barford 1
The anaphase-promoting complex/cyclosome (APC/C) orchestrates cell cycle progression
by controlling the temporal degradation of specific cell cycle regulators. Although cyclin A2
and cyclin B1 are both targeted for degradation by the APC/C, during the spindle assembly
checkpoint (SAC), the mitotic checkpoint complex (MCC) represses APC/C’s activity
towards cyclin B1, but not cyclin A2. Through structural, biochemical and in vivo analysis, we
identify a non-canonical D box (D2) that is critical for cyclin A2 ubiquitination in vitro and
degradation in vivo. During the SAC, cyclin A2 is ubiquitinated by the repressed APC/C-
MCC, mediated by the cooperative engagement of its KEN and D2 boxes, ABBA motif, and
the cofactor Cks. Once the SAC is satisfied, cyclin A2 binds APC/C-Cdc20 through two
mutually exclusive binding modes, resulting in differential ubiquitination efficiency. Our
findings reveal that a single substrate can engage an E3 ligase through multiple binding
modes, affecting its degradation timing and efficiency.
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Controlled cell-cycle progression is governed by the inter-play of ordered protein degradation and reversible proteinphosphorylation. In eukaryotes, the anaphase-promoting
complex/cyclosome (APC/C), through targeting specific cell-cycle
regulators for degradation, regulates chromatid segregation at
the metaphase to anaphase transition, the exit from mitosis and
the establishment and maintenance of G11–3. APC/C-substrate
selection is controlled by two coactivator subunits, Cdc20 and
Cdh1, that recognize three major classes of degrons: the
destruction box (D box)4, KEN box5 and ABBA motif6–9. In
addition, coactivators stimulate APC/C catalytic activity10–12.
The spindle assembly checkpoint (SAC) ensures the equal
distribution of chromosomes to the two daughter cells by
arresting the cell in metaphase until all chromosomes are cor-
rectly attached to kinetochores13,14. In prometaphase, the APC/C
targets cyclin A2 for degradation, whereas its activity towards
securin and cyclin B1 is suppressed by the SAC13,14. Early
degradation of cyclin A2, preceding anaphase onset, is important
as a persistent level of cyclin A2 prevents the stable kinetochore-
microtubule attachments necessary for chromosome segrega-
tion15. Consequently, increased levels of cyclin A2 in mammalian
cells delayed metaphase and anaphase onset16,17, and are asso-
ciated with a variety of tumours18. Transgenic mice over-
expressing cyclin A2 in mammary glands exhibited hyperplasia
and nuclear abnormalities19. These studies underlie the impor-
tance of understanding the mechanisms responsible for targeted
cyclin A2 degradation.
Cyclin A2 is degraded in prometaphase about 30 min before
cyclin B116,17, due to the SAC-imposed inhibition of the APC/C
towards cyclin B1. The SAC represses APC/CCdc20 activity
through its effector, the mitotic checkpoint complex (MCC), a
tetrameric-protein complex consisting of Cdc20, BubR1, Bub3
and Mad220. Through its BubR1 subunit, the MCC inhibits APC/
CCdc20 by both acting as a pseudo-substrate that blocks all six
degron-binding sites on both Cdc20 subunits of APC/CMCC
(refs. 21–23), and obstructing the E2 binding site to suppress APC/
C’s catalytic activity22,23.
Both the N-terminal 165 residues of human cyclin A2 and the
Cdk-associated cofactor Cks are necessary and sufficient to allow
SAC-resistant degradation of cyclin A216,24,25, yet the exact
degrons responsible for cyclin A2 degradation are unknown.
Unlike cyclin B1, deletion of the canonical D box in cyclin A2 had
no influence on either the timing or the rate of its
degradation16,17,26,27, and the D box failed to function as a por-
table destruction signal28,29, implying that the canonical D box of
cyclin A2 may be dispensable. Here, we identify a previously
uncharacterized non-canonical D box (D2 box) in cyclin A2. We
define the roles of individual degrons in cyclin A2 and how they
cooperate to overcome repression of cyclin A2 ubiquitination by
the MCC. Our data indicate that the MCC-repressed state of the
APC/C (APC/CMCC) is responsible for ubiquitinating cyclin A2
during an active SAC by directly engaging cyclin A2. Further-
more, we reveal two distinct binding modes of cyclin A2 to APC/
CCdc20 that influence its ubiquitination efficiency.
Results
Known degrons of cyclin A2 are dispensable for APC/CCdc20
activity. The cell-cycle dependent ordering of substrate degra-
dation is governed by different states of APC/C activity, degron
affinity and substrate processivity as well as competition among
substrates and modification of degrons7,30–36. Because Cdk2-
cyclinA2-Cks2 functions both as a kinase and substrate of the
APC/C, to understand how cyclin A2 evades the spindle assembly
checkpoint, we performed ubiquitination assays in the presence
of the Cdk1/2 inhibitor iii. In the absence of this inhibitor, cyclin
A2 ubiquitination is suppressed due to Cdc20 phosphorylation
(Supplementary Fig. 1a). In vitro, cyclin A2 and cyclin B1 are
substrates of both APC/CCdc20 (phosphorylated APC/C) and
APC/CCdh1, independent of complex formation with Cdk2-Cks2
(Supplementary Fig. 1b, c, e). However, unlike cyclin B1, cyclin
A2 was processively ubiquitinated in the presence of the MCC
(Supplementary Fig. 1d). Nevertheless, cyclin A2 alone is not
sufficient and it requires the associated cofactor Cdk-Cks to
overcome the MCC-imposed inhibition of APC/C activity (Sup-
plementary Fig. 1d), consistent with previous studies in vivo24.
The ability of Cdk2-cyclinA2-Cks2 to overcome the MCC-
mediated inhibition of APC/C activity in vitro is dependent on its
concentration. At lower concentrations cyclin A2 ubiquitination
was inhibited by the MCC, whereas increasing the cyclin A2
concentration allowed it to effectively overcome MCC-imposed
inhibition (Supplementary Fig. 1f). The concentrations of the
APC/C, MCC and Cdc20 used in the ubiquitination assays are
within the range of their reported physiological intracellular
concentrations37,38, whereas those of Cdk2-cyclin substrates are
substantially higher than that reported in ref. 39.
In both cyclin A2 and cyclin B1, degrons present within their
N-terminal domains target the cyclins for ubiquitination by the
APC/C4,28,40 (Fig. 1a). In addition to the canonical D box
(referred as the D1 box), cyclin A2 contains a putative KEN box
(DQEN)41 and an ABBA motif6 (Fig. 1a). To verify the roles that
individual degrons play in targeting cyclin A2 to the APC/C,
cyclin A2 mutants were generated in which each degron was
mutated individually. Mutation of the putative KEN box (ΔK)
alone completely abolished cyclin A2 ubiquitination by APC/
CCdh1, whereas mutation of the canonical D box (ΔD1) and the
ABBA motif (ΔA) did not have an effect (Fig. 1b, c, lanes 1–3 and
5 and Supplementary Fig. 2a). This verified the existence of a
KEN box in cyclin A2 and is in agreement with previous findings
that the KEN box is important for substrate recognition by APC/
CCdh1 (ref. 5). On the other hand, individual mutation of the KEN
box (ΔK), the D1 box (ΔD1) and the ABBA motif (ΔA) did not
impair cyclin A2 ubiquitination by APC/CCdc20 (Fig. 1d, e and
Supplementary Fig. 2b). Mutating the KEN box or ABBA motif
reduced cyclin A2 ubiquitination by APC/CMCC, whereas in
contrast, disrupting the canonical D1 box had no effect (Fig. 1f, g
and Supplementary Fig. 2c). Therefore, mutation of the canonical
D1 box did not decrease cyclin A2 ubiquitination in vitro by
APC/CCdh1, APC/CCdc20 or APC/CMCC, suggesting that the D1
box is dispensable for its ubiquitination. This is consistent with
findings that the D1 box is not required for cyclin A2 degradation
in cells24.
To assess whether our in vitro assays reflect the role of cyclin
A2 degrons in controlling cyclin A2 degradation in vivo, we
introduced cyclin A2 harbouring degron mutations tagged with
enhanced GFP into HEK293 FlpIn-TRex cells and monitored
their degradation pattern in vivo using live cell microscopy
(Fig. 1h–j and Supplementary Movies 1, 2). The expression of
cyclin A2 mutant proteins in these cell lines can be finely
controlled by addition of doxycyline (Supplementary Fig. 3a) and
a concentration was chosen to reflect the expression level of
endogenous cyclin A2. While we cannot formally exclude that
doubling the protein levels of cyclin A2 in cells by this approach
influences the degree of phosphorylation present on Cdk/cyclin
substrates, this effect seems to be negligible, because mitotic
timing is not altered upon expression of different cyclin A2
mutants (except for non-degradable cyclin A2 mutants, see
below) (Supplementary Fig. 3b). Single mutations of individual
degrons (KEN box, D1 box or ABBA motif) showed similar
destruction timing and kinetics as wild-type cyclin A2 (Fig. 1h, j
and Supplementary Fig. 3c, d), consistent with the negligible
effect of disrupting these degrons in the in vitro assays for
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APC/CCdc20 and APC/CMCC. However, when the HEK cells were
arrested with the kinesin-like 11/Eg5 inhibitor S-trityl-L-cysteine
(STLC) in prometaphase with an active SAC, all three single
degron mutations resulted in a decreased rate of cyclin A2
degradation (Supplementary Fig. 3e), and a slight delay in
destruction timing compared to wild-type cyclin A2 (Fig. 1i),
implying they may contribute to the SAC-resistant degradation of
cyclin A2 in vivo.
To further explore the determinants of cyclin A2 ubiquitina-
tion, a mutant was generated with all three known degrons
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disrupted (ΔKD1A). Strikingly, this ΔKD1A mutant was
efficiently ubiquitinated by APC/CCdc20 to a similar extent as
wild-type cyclin A2 (Fig. 2a, compare lanes 1 and 4). However,
unlike wild-type cyclin A2, ubiquitination of the cyclin A2ΔKD1A
mutant was virtually abolished in the presence of the MCC,
indicating a loss of resistance to the MCC (Fig. 2a, compare lanes
2, 3 and 5, 6). In vivo, degradation of the ΔKD1A mutant was
delayed to anaphase during an unperturbed mitosis, reminiscent
of wild-type cyclin B1 (Fig. 2c, Supplementary Fig. 3c and
Supplementary Movies 3, 4). Under a SAC arrest, the ΔKD1A
mutant was partially stabilized until it was rapidly degraded by
APC/CCdc20 when the SAC was inactivated using Mps1 kinase
inhibitor reversine42 (Fig. 2d). These findings suggested the
possibility that an unidentified degron(s) is present in cyclin A2
to target its ubiquitination by APC/CCdc20, and contribute to
cyclin A2 degradation in vivo.
Identification of a non-canonical degron in cyclin A2. Previous
findings showed that deletion of the N-terminal 60 residues failed
to stabilize cyclin A2, whereas deletion of the first 80 residues
prevented its degradation17. This raised the possibility that the
region between residues 60–80 may play a role in targeting cyclin
A2 for degradation, although a canonical degron was not iden-
tified. To investigate whether a previously unidentified degron is
present within this region, residues within 60–80 of cyclin A2
were replaced with GSA-linkers and combined with the ΔKD1A
mutation. Strikingly, mutating residues 65–75 or 70–80 in addi-
tion to ΔKD1A completely abolished cyclin A2 ubiquitination by
APC/CCdc20 (Fig. 2b, lanes 4 and 5). Furthermore, a peptide
modelled on residues 60–80 suppressed ubiquitination of the
cyclin A2 ΔKD1A mutant by APC/CCdc20 (Fig. 2e). These results
indicated that an unidentified degron, lying within residues
70–80, contributes to the targeting of cyclin A2 for ubiquitination
by APC/CCdc20. Combining the ΔKD1A mutation with mutation
of residues 70–80 (designated D2, see below) (equal to Δall) also
abolished the resistance of cyclin A2 ubiquitination to the MCC-
imposed inhibition of APC/C activity (Fig. 1f, g lane 6).
In agreement with our in vitro analysis, mutation of residues
70–80 combined with the ΔKD1A mutation (Δall) completely
stabilized cyclin A2 in vivo both in unperturbed and SAC arrested
cells, leading to prolonged mitosis and disruption of cell division
(Fig. 2c, d and Supplementary Fig. 3b–e). The unperturbed HEK
cells expressing the cyclin A2 Δall mutant initially aligned their
chromosomes, but failed to maintain a metaphase plate
(Supplementary Fig. 3c and Supplementary Movie 5), consistent
with previous results, suggesting a role for cyclin A2 in regulating
kinetochore-microtubule attachments15.
Residues 70–81 of cyclin A2 contains the sequence
72VxxLxDLxx81N, similar to the consensus sequence of a
canonical D box except for a Val substitution of Arg at position
1 (P1) (Fig. 2g). Nonetheless, exceptions for an Arg at the P1
residue have been observed for the D boxes of other APC/C
substrates9,41. We named this new putative D box as the D2 box.
The D2 box sequence is highly conserved among mammals
ranging from human to mouse (Fig. 2f, g). Mouse and rat cyclin
A2 have lost the D1 box and retained only the D2 box (Fig. 2f, g).
To verify whether the newly identified degron is indeed a D
box, a competition assay was performed using a D box peptide
modelled on the high affinity yeast substrate Hsl143,44. Addition
of the Hsl1 D box peptide potently inhibited ubiquitination of the
cyclin A2 ΔKD1A mutant (with only the D2 box present) (Fig. 3a,
lanes 4–6), indicating that both the Hsl1 D box peptide and the
D2 box of cyclin A2 compete for the same binding site on APC/
CCdc20. Moreover, point mutations of the consensus residues of
the D2 box to alanines (D2mut2) combined with the ΔKD1A
mutation ablated cyclin A2 ubiquitination by APC/CCdc20
(Fig. 3b, c lane 3), reminiscent of mutating all four degrons
(Δall) in cyclin A2 (Fig. 3b, c lane 4). The assignment of the
identified degron as a D box is consistent with the finding that
mutations in residues 81–90 containing an Asn at P10 reduced
cyclin A2 ubiquitination (Fig. 2b, lane 6), as C-terminal
hydrophilic residues of the D box are involved in interactions
with Apc1045–48. In addition, the D2 box of cyclin A2 can
function as a portable destruction signal in other APC/C
substrates, as insertion of the D2 box into a securin mutant
lacking its native D box rescued its ubiquitination by APC/CCdc20
(Fig. 3d).
Cyclin A2 engages APC/CCdc20 in two different binding modes.
To identify whether the D2 box of cyclin A2 associates with APC/
CCdc20 in the same way as a canonical D box, we determined the
cryo-EM structure of APC/CΔApc1-300s in complex with Cdc20
and wild-type Cdk2-cyclinA2-Cks2 to 3.2 Å resolution (Fig. 4a,
Supplementary Figs. 4a–c, f, 5 and Supplementary Table 1). APC/
CΔApc1-300s is a constitutively active APC/C mutant that mimics
wild-type phosphorylated APC/C48. Focused three-dimensional
(3D) classification identified a large movement of the Cdc20
WD40 domain that is responsible for substrate recognition
(Supplementary Fig. 5h), limiting its local resolution to 4.5–5.5 Å
(Supplementary Fig. 5e, g). Notably, EM densities corresponding
to the globular domains of Cdk2-cyclinA2-Cks2 were not visible,
indicating their conformational flexibility. Two major 3D classes
from the same dataset using wild-type Cdk2-cyclinA2-Cks2 as a
substrate were characterized, corresponding to either the D1 box
Fig. 1 Mutation of individual cyclin A2 degrons did not abolish its ubiquitination and degradation. a Domain organization of human cyclin A2 and cyclin B1,
with their respective degrons indicated. DQEN and NAEN are the putative KEN boxes. b–g Ubiquitination assays of single degron mutations in cyclin A2 by
APC/CCdh1 (b), APC/CCdc20 (d) and APC/CMCC (f). In vitro phosphorylated APC/C was used for complex formation with Cdc20 and the MCC, while
unphosphorylated APC/C was used for Cdh1. The remaining degrons in cyclin A2 after the mutation are labelled in dark red. Ubiquitination reactions were
analysed by Western blotting with an anti-His antibody to detect the ubiquitin-modified substrates. Control gels showing the unmodified substrate for
representative reactions are shown in Supplementary Fig. 2. The western-blots were quantified, with error bars indicating standard deviation. The APC/C
activity towards cyclin A2 mutants is normalized to ubiquitination of wild-type cyclin A2 and the significance is calculated using unpaired Student’s t-test
(indicated with stars, n= 3 for c and 2 for e and g, Supplementary Table 2). h, i Degradation profiles of single degron mutation constructs of eGFP-cyclin
A2 in HEK cells during unperturbed mitosis (h) and a SAC arrest using STLC (i). Under unperturbed mitosis, n= 62 wild-type, 49 ΔK, 47 ΔD1, 44 ΔD2 and
37 ΔA cells were analysed, whereas 13 wild-type, 14 ΔK, 15 ΔD1, 22 ΔD2 and 12 ΔA cells were analysed for conditions under a SAC arrest. The timepoints
of NEBD and reversine addition to release the SAC arrest are marked, respectively. j Exemplary still images from time courses between NEBD and
anaphase of eGFP-cyclin A2 destruction in HEK cells of wild-type cyclin A2 and the ΔD2 mutant. The chromosomes are coloured in magenta and cyclin A2
in green, with the outline of the cells marked with dashed yellow lines. Time is given as hh:mm. Scale bar 10 μm. Degradation of cyclin A2 is slightly delayed
in the absence of the D2 box (compare the two cells at 15 and 21 min). The complete time courses are shown as Supplementary Movies 1 and 2. Source
data are provided as a Source Data file
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or D2 box bound to Cdc20WD40 (Fig. 4b, d and Supplementary
Fig. 5d, f). Assignment of the two 3D classes to the D1 and D2
boxes was based on a cryo-EM structure of APC/CΔApc1-300s in
complex with Cdc20 and Cdk2-cyclinA2ΔD1-Cks2 lacking the D1
box, determined to 3.7 Å resolution (Fig. 4c and Supplementary
Fig. 4f). In this structure, only a C-shaped density connecting
Cdc20WD40 and Apc10 was observed (Fig. 4c), identifying this
density as the D2 box. In complexes of APC/CCdc20 with both
wild-type Cdk2-cyclinA2-Cks2 and Cdk2-cyclinA2ΔD1-Cks2, the
D2 box forms a C-shaped loop connecting Cdc20WD40 and
Apc10 (Fig. 4b, c), resembling the Hsl1 D box that is bound to
APC/CCdc20 (ref. 48) (Fig. 4g). In contrast, the D1 box class of
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wild-type Cdk2-cyclinA2-Cks2 in complex with APC/CCdc20
differs from the D2 box class due to a 20 Å shift of Cdc20WD40,
with a distinct long-kinked loop structure assigned to the D1 box
(Fig. 4d, e and Supplementary Fig. 5h). Superposition of the two
classes onto Cdc20WD40 revealed that the N-terminal segment of
both the D1 and D2 boxes are similar (Fig. 4e, f). However, unlike
the D2 box, the C-terminal region of the D1 box folds back and is
sandwiched between Cdc20WD40 and Apc10.
Fig. 2 An unidentified degron conserved among mammals is present in cyclin A2. a Mutation of all three known degrons (KEN box, D1 box and ABBA
motif) in cyclin A2 did not impair cyclin A2 ubiquitination by APC/CCdc20 (compare lanes 1 and 4). However, the mutant cyclin A2ΔKD1A is subject to
MCC-imposed inhibition (lanes 4–6), similar to Cdk2-cyclinB1-Cks2 (lanes 7–9). The remaining degrons in cyclin A2 after the mutation are labelled in dark
red. b Replacing overlapping segments within residues 60–80 of cyclin A2 with GSA-linkers identified that residues 70–80 may contain an unidentified
degron. Mutation of either residues 65–75 or 70–80 in addition to ΔKD1A severely impaired cyclin A2 ubiquitination by APC/CCdc20. c, d Degradation
profiles of the eGFP-cyclin A2 mutants where either the KD1A degrons (leaving the D2 box present) or all four degrons were mutated in HEK cells under
unperturbed mitosis (c) and a SAC arrest using STLC (d). Degradation pattern of cyclin B1 was recorded as a reference. The total eGFP fluorescence minus
background fluorescence for each cell at each time point was normalized to NEBD, quantified and plotted over time. The timepoints of NEBD and reversine
addition to release the SAC arrest are marked, respectively. Error bars indicate mean ± standard deviation of n= 62 wild-type cyclin A2, 24 ΔKD1A, 37 Δall
and 45 wild-type cyclin B1 cells under unperturbed mitosis and 13 wild-type cyclin A2, 11 ΔKD1A and 19 Δall cells under a SAC arrest from three
experiments. e Addition of a peptide modelled on residues 60–80 of cyclin A2 inhibited ubiquitination of the cyclin A2 ΔKD1A mutant, confirming that this
region targets cyclin A2 for ubiquitination. f, g Sequence alignment of the N-terminal domain of cyclin A2 and phylogenic tree. Positions of the four degrons
are indicated. All cyclin A2 sequences used in the sequence alignment contain the D1 box (except for mouse and rat), whereas the D2 box appeared at a
later stage of evolution. Source data are provided as a Source Data file
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When the D2 box is engaged, weak densities accounting for the
KEN box were observed on the top surface of Cdc20WD40,
whereas the ABBA-motif-binding pocket was unoccupied (Fig. 4b,
c). A minimal distance of 60 Å required to bridge the D2 box and
ABBA motif makes the ABBA-motif-binding pocket out of reach
when the D2 box is bound (Fig. 4b). In addition, the C-terminus
of the D2 box is directed away from the ABBA-motif-binding
pocket due to Apc10 (Fig. 4b, c). Interestingly, strong EM
densities for both the KEN box and ABBA motif were observed
when the D1 box was bound (Fig. 4d). With a distance of 41
residues to the ABBA motif, the D1 box is within reach of the
ABBA-motif-binding site. Furthermore, unlike the D2 box, the C-
terminus of the D1 box is directed around Cdc20WD40 towards
the ABBA-motif-binding pocket (Fig. 4d, f). These observations
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indicate that cyclin A2 can engage APC/CCdc20 with two distinct
binding modes (Fig. 4h–j).
The D2 box of cyclin A2 is critical for its ubiquitination. The
newly identified D2 box is important for cyclin A2 ubiquitination
by APC/CCdh1, APC/CCdc20 and APC/CMCC, as mutating the D2
box alone (ΔD2) resulted in a reduced level of cyclin A2 ubi-
quitination in all three instances (Fig. 1b–g). Specifically, the
cyclin A2 ΔD2 mutant was the only single degron mutation that
resulted in a reduction of cyclin A2 ubiquitination by APC/
CCdc20 (Fig. 1d, e and Table 1). In agreement with the in vitro
assays, live cell imaging showed that relative to other single
degron mutations, disruption of the D2 box caused the longest
delay in cyclin A2 degradation (to around metaphase) (Fig. 1h–j).
Nevertheless, the single absence of the D2 box did not fully sta-
bilize cyclin A2 in cells (Fig. 1h, i). This indicates that in addition
to the D2 box, the other three cyclin A2 degrons contribute to its
degradation in vivo.
To explore the roles of individual degrons, we performed a
comprehensive analysis of degron mutations in cyclin A2
(Table 1). We found that the newly identified D2 box contributes
to the major activity of APC/CCdc20, augmented by the KEN box
(Fig. 5a, b and Supplementary Fig. 2b). A cyclin A2 mutant with
only the D2 box present (ΔKD1A) is ubiquitinated by APC/
CCdc20 to the same extent as wild-type cyclin A2, while addition
of the KEN box slightly enhanced its ubiquitination (Fig. 5a, b,
compare lanes 1, 4 and 7). In contrast to APC/CCdc20, the KEN
box plays a major role for cyclin A2 ubiquitination by APC/
CCdh1, augmented by the D2 box (Supplementary Fig. 1g, h,
compare lanes 1 and 7, 2a).
Interestingly, combining the D1 box with either the ABBA
motif or the KEN box allowed cyclin A2 ubiquitination at a
low level (Fig. 5a, b lanes 6 and 10), indicating that in the
absence of D2, D1 cooperates with the ABBA motif and KEN box
to promote cyclin A2 ubiquitination by APC/CCdc20. This
result is consistent with the cryo-EM reconstructions of the
APC/CΔApc1-300s-Cdc20-Cdk2-cyclinA2-Cks2 complex revealing a
mixed population of conformations, with either D1 or D2
interacting with APC/CCdc20 (Fig. 4b, d). In support of this idea,
disrupting the P1-Arg-binding site of the Cdc20 D-box receptor
(Argmut) resulted in enhanced cyclin A2 ubiquitination by APC/
CCdc20, while it strongly impaired securin ubiquitination (Fig. 3e,
compare lanes 1–3 and 7–9). Disruption of the P1-Arg-binding
site would favour the engagement of D2, leading to enhanced
ubiquitination of cyclin A2. Therefore, two mutually exclusive
binding modes allow cyclin A2 ubiquitination by APC/CCdc20
(Fig. 4h–j), resulting in different efficiency of cyclin A2
ubiquitination (Fig. 4k). The D2 box is self-sufficient for cyclin
A2 ubiquitination and is augmented by the KEN box (Fig. 4i),
whereas the weak D1 box requires cooperative binding of the
KEN box and ABBA motif (Fig. 4j).
In the presence of the MCC, none of the four identified
degrons alone (KEN, D1, D2, ABBA) was sufficient to promote
cyclin A2 ubiquitination in vitro (Fig. 5c, d, compare lanes 1–5
Fig. 4 Cyclin A2 engages APC/CCdc20 with two binding modes. a Cryo-EM reconstruction of the constitutive active mutant APC/CΔApc1-300s in complex
with Cdc20 and Cdk2-cyclinA2-Cks2 at 3.2 Å resolution, with the D2 box and KEN box density highlighted in orange, Cdc20 in purple and Apc10 in blue.
Individual chains of the APC/CCdc20-Hsl1 structure were fitted into the EM density (PDB 5G0448). Coordinates for Cdc20, Apc10 and the D2 box and KEN
box of cyclin A2 are coloured according to the density, with the remaining APC/C subunits in grey. b Close-up view of the degron-binding site when the D2
box occupies the D-box binding site. No densities corresponding to the ABBA motif could be found in its binding pocket (dashed black line). c Close-up
view of the degron-binding site when the ΔD1 mutant was used as a substrate which closely resembles the D2 box class of the wild-type structure.
d Close-up view of the degron-binding site in the D1 box class when wild-type Cdk2-cyclinA2-Cks2 was used as a substrate reveals that the D1 box binds to
APC/CCdc20 in cooperation with the KEN box and ABBA motif. e Superposition of the D1 box and D2 box classes on Apc10 revealed a large movement of
Cdc20WD40. The D1 box is depicted in orange while the D2 box in yellow. Cdc20WD40 from the D1 box class is in dark purple, while that of the D2 box
class in pale purple. f Superposition of the two classes on Cdc20WD40 showed that the D2 box overlaps well with the N-terminal region of the D1 box, yet
the C-terminal segment of the D1 box folds back with a kink to be sandwiched between Cdc20WD40 and Apc10. g Superposition of the cyclin A2 D2 box
structure with the structure of the canonical D box of Hsl1 (PDB 5G0448). h–j Schematic cartoon showing the two different binding modes of cyclin A2 to
APC/CCdc20. k Ubiquitination assay showing different ubiquitination efficiency of the two binding modes of cyclin A2 to APC/CCdc20. Source data are
provided as a Source Data file
Table 1 Summary of the effects of cyclin A2 degron
mutations to its ubiquitination
Degron
mutation
APC/CCdc20 APC/CMCC Degrons
present
KEN box mutations
ΔK alone Same as WT Lower D1D2A
ΔKD1 Same as WT Lower D2A
ΔKD2 Lower Lower D1A
ΔKA Same as WT No activity D1D2
ΔKD1D2 No activity No activity A
ΔKD1A Same as WT No activity D2
ΔKD2A No activity No activity D1
ΔKD1D2A No activity No activity None
D1 box mutations
ΔD1 alone Higher Same as WT KD2A
ΔKD1 Same as WT Lower D2A
ΔD1D2 No activity No activity KA
ΔD1A Higher Lower KD2
ΔKD1D2 No activity No activity A
ΔKD1A Same as WT No activity D2
ΔKD2A No activity No activity K
ΔKD1D2A No activity No activity None
D2 box mutations
ΔD2 alone Lower Lower KD1A
ΔKD2 Lower Lower D1A
ΔD1D2 No activity No activity KA
ΔD2A Lower No activity KD1
ΔKD1D2 No activity No activity A
ΔKD2A No activity No activity D1
ΔD1D2A No activity No activity K
ΔKD1D2A No activity No activity None
ABBA motif mutations
ΔA alone Higher Lower KD1D2
ΔKA Same as WT No activity D1D2
ΔD1A Higher Lower KD2
ΔD2A Lower No activity KD1
ΔKD1A Same as WT No activity D2
ΔKD2A No activity No activity D1
ΔD1D2A No activity No activity K
ΔKD1D2A No activity No activity None
Any combinations with the D2 box mutated resulted in a reduction or elimination of cyclin A2
ubiquitination by both APC/CCdc20 and APC/CMCC
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and Supplementary Fig. 2c). The D2 box is the dominating
determinant, and addition of either the KEN box or the ABBA
motif to D2 resulted in cyclin A2 ubiquitination by APC/CMCC
that approached wild-type levels (Fig. 5c, d, compare lanes 1, 7
and 11). Consistent with the in vitro assays, a combination of D2
with either the KEN box or ABBA motif advanced cyclin A2
degradation in HEK cells to an earlier time point compared to
when D2 was present alone, during both an unperturbed mitosis
and a SAC arrest (Fig. 2c, d and Fig. 5e, f). These results suggest
that the KEN box and ABBA motif work cooperatively with D2 to
allow cyclin A2 to overcome the MCC-imposed inhibition of
APC/C activity.
A dominant role for the D2 box raised the question of why
human cyclin A2 retained the D1 box. A titration of the cyclin A2
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Fig. 5 A cooperation of multiple degrons confers the resistance of cyclin A2 to MCC-imposed inhibition. a–d Ubiquitination assays of double and triple
degron mutations in cyclin A2 by APC/CCdc20 (a) and APC/CMCC (c). In all assays, cyclin A2 is in complex with Cdk2-Cks2. The D2 box is the critical
determinant for cyclin A2 ubiquitination by APC/CCdc20 (compare lanes 1, 4, 7, 9 and 11 in a). To resist MCC-mediated inhibition, cyclin A2 requires both
the KEN box and ABBA motif together with the D2 box (compare lanes 1, 7 and 11 in c). The remaining degrons in cyclin A2 after the mutation are labelled
in dark red. Ubiquitination reactions were analysed by western blotting with an anti-His antibody to detect the His-tag of the ubiquitin-modified substrates.
Control gels indicating the unmodified substrate for representative reactions are shown in Supplementary Fig. 2. The western-blots were quantified to show
the effect of individual mutations, with error bars indicating standard deviation. The APC/C activity towards cyclin A2 mutants is normalized to
ubiquitination of wild-type cyclin A2 and significance is calculated using unpaired Student’s t-test (indicated with stars, n= 4 for b and 3 for d,
Supplementary Table 2). e, f Degradation profiles of the eGFP-cyclin A2 double degron mutants in HEK cells under unperturbed mitosis (e) and a SAC
arrest using STLC (f). The total eGFP fluorescence minus background fluorescence for each cell at each time point was normalized to NEBD, quantified and
plotted over time. The timepoints of NEBD and reversine addition to release the SAC arrest are marked, respectively. Error bars indicate mean ± standard
deviation of n= 62 wild-type, 33 ΔKD1, 58 ΔKD2, 34 ΔKA, 28 ΔD1D2, 48 ΔD1A and 23 ΔD2A cells under unperturbed mitosis and 13 wild-type, 15 ΔKD1,
12 ΔKD2, 20 ΔKA, 12 ΔD1D2, 19 ΔD1A and 13 ΔD2A cells under a SAC arrest from three experiments. Source data are provided as a Source Data file
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ΔD1 mutant revealed that at lower concentrations (0.18–
0.48 μM), disrupting D1 reduced cyclin A2 ubiquitination by
APC/CMCC (Supplementary Fig. 1i, j compare lanes 1 and 2 with
5 and 6), consistent with the observation that D1 contributes to
cyclin A2 degradation during a SAC arrest in HEK cells (Fig. 1i
and Supplementary Fig. 3e). These results imply that D1 may
increase the avidity of cyclin A2 as a substrate to APC/CMCC.
Cyclin A2 is targeted by the repressed APC/CMCC. It had pre-
viously been suggested that the ABBA motif of cyclin A2 confers
resistance to the MCC-mediated inhibition of APC/CCdc20 by
outcompeting BubR1, thereby allowing its binding to the acti-
vating Cdc20A (Cdc20 of the APC/C) subunit to be ubiquitinated
by APC/CCdc20 (ref. 6,24). To test this hypothesis, we incubated
pre-formed and purified APC/CMCC with wild-type Cdk2-
cyclinA2-Cks2 and analysed the complex by size exclusion
chromatography. A complex of APC/CMCC-Cdk2-cyclinA2-Cks2
was formed, with no evident dissociation of the MCC from APC/
CCdc20 (Fig. 6a–d). This result suggests an alternative model in
which the MCC and Cdk2-cyclinA2-Cks2 simultaneously interact
with APC/CCdc20. In this model, cyclin A2 binds to and is ubi-
quitinated by the repressed APC/CMCC. Mutation of the cyclin
A2 ABBA motif resulted in slightly reduced binding of Cdk2-
cyclinA2ΔABBA-Cks2 to APC/CMCC (Supplementary Fig. 6a),
consistent with our findings that the ABBA motif is required to
confer cyclin A2’s resistance to the MCC-imposed inhibition of
APC/C activity.
Within APC/CMCC, there are two Cdc20 subunits21–23 and
therefore, two binding sites for each degron (Fig. 7a). To
determine which of the two Cdc20 subunits engages cyclin A2’s
ABBA motif, mutations (I235S and Y279E)6 were introduced into
Cdc20 to disrupt the ABBA-motif-binding pocket (Supplementary
Fig. 6b) on either Cdc20A (Cdc20 of the APC/C) or Cdc20M
(Cdc20 of the MCC). Strikingly, disrupting the ABBA-motif-
binding site on Cdc20M strongly impaired the resistance of cyclin
A2 to MCC-imposed inhibition of APC/C activity (Fig. 6e, f, lanes
7–9), whereas the equivalent mutation in Cdc20A did not affect
cyclin A2 ubiquitination in the presence of the MCC (Fig. 6e, f,
lanes 4–6). The opposite effect was observed for securin where
mutation of Cdc20M weakened the inhibitory strength of the
MCC to securin ubiquitination (Supplementary Fig. 6c). There-
fore, the loss of resistance to MCC-imposed inhibition caused by
disrupting the ABBA-motif-binding pocket in Cdc20M is unique
to cyclin A2, indicating that the ABBA motif of cyclin A2 interacts
with Cdc20M. Similarly, a mutation disrupting the interactions of
hydrophobic residues within the D-box binding pocket (L176A)
revealed that the D2 box of cyclin A2 engages the Cdc20M subunit
of APC/CMCC (Fig. 6g, h and Supplementary Fig. 6d).
An attempt to determine the cryo-EM structure of the APC/
CMCC-Cdk2-cyclinA2-Cks2 complex did not reveal additional
densities accounting for Cdk2-cyclinA2-Cks2 (Supplementary
Figs. 4d–f, 6e and Supplementary Table 1). Thus we cannot
distinguish the degrons bound to the APC/CMCC degron
recognition sites are derived from the MCC or cyclin A2.
Nonetheless, a four-fold increase in the ratio between the open
and closed states of APC/CMCC was observed in the presence of
Cdk2-cyclinA2-Cks2 compared to a control dataset collected for
APC/CMCC alone (Supplementary Fig. 6e). With this observation
we speculate that Cdk2-cyclinA2-Cks2 may bind to APC/CMCC
and induce an open conformation of APC/CMCC to enable cyclin
A2 ubiquitination. When in the open state, the catalytic module
of the APC/C (Apc2-Apc11) is accessible to engage the E222,23.
Cooperative binding of multiple degrons allows cyclins to
resist the SAC. Our results reveal that the resistance of cyclin A2
to MCC-imposed inhibition of APC/C activity is conferred by
cooperative binding of four factors: the KEN box, D2 box, ABBA
motif and its associated Cks (Fig. 7a, b and Table 1). To confirm
that the major determinant of SAC-resistant cyclin A2 degrada-
tion is the KEN-Dbox-ABBA cassette, we tested if we could
convert the metaphase substrate cyclin B1, whose degradation is
suppressed by the MCC, into a prometaphase substrate that can
be ubiquitinated by APC/CMCC. Cyclin B1 lacks both the KEN
box and ABBA motif, as mutation of a putative KEN box
(NAEN) in cyclin B1 failed to impair its ubiquitination by either
APC/CCdh1 or APC/CCdc20, and cyclin B1 ubiquitination
remained repressed by the MCC (Supplementary Fig. 6f). Inser-
tion of the cyclin A2 KEN box alone failed to enhance cyclin B1
ubiquitination by APC/CMCC (Fig. 7c, d, compare lanes 2, 4 and
6). On the other hand, insertion of the ABBA motif into cyclin B1
conferred partial resistance of cyclin B1 to MCC-mediated inhi-
bition (Fig. 7c, d, lanes 7 and 8). Insertion of both the KEN box
and ABBA motif into cyclin B1 allowed for its ubiquitination by
APC/CMCC, with a relative activity comparable to that of wild-
type cyclin A2 (Fig. 7c, d, compare lanes 9 and 10 to 11 and 12).
Discussion
A long-standing puzzle has been how the cell-cycle-dependent
change of substrate selection by the APC/C is achieved, in par-
ticular, how cyclin A2 evades the SAC to allow its degradation at
prometaphase, whereas cyclin B1 and securin remain stable.
Progression from prometaphase to metaphase requires destruc-
tion of cyclin A2, as persistent levels of cyclin A2 prevent stable
kinetochore-microtubule attachments, thereby disrupting faithful
chromosome segregation15. Despite its importance, the mechan-
istic details of how cyclin A2 resists the MCC-imposed inhibition
of APC/C activity and the roles of individual degrons in cyclin A2
remained to be defined. In this study we identified a non-
canonical D box (D2 box) in cyclin A2 that is critical for its
efficient ubiquitination. Mutation of the D2 box reduced cyclin
A2 ubiquitination by APC/CCdh1, APC/CCdc20 and APC/CMCC
(Table 1). Moreover, it is the only degron that is self-sufficient to
allow cyclin A2 ubiquitination by APC/CCdc20. To overcome
MCC-imposed inhibition, cyclin A2 requires not only the pre-
viously characterized ABBA motif, but also its KEN box and
D2 box.
In addition, we found that Cdk2-cyclinA2-Cks2 forms a stable
complex with APC/CMCC, without dissociating the MCC. Within
APC/CMCC, BubR1 blocks all six degron-binding sites on both
Cdc20 subunits with two copies of the KEN box, D box and
ABBA motif22,23 (Fig. 7a, b). Our data suggest that the ABBA
motif of cyclin A2 associates with Cdc20M by displacing the
second ABBA motif (A2) of BubR1. With its strong ABBA motif
sequences (Fig. 2g), cyclin A2 is capable of competing off the
weaker A2 motif of BubR16. This is consistent with previous
results that mutation of the first ABBA motif (A1) in BubR1, that
interacts with Cdc20A, dissociated the MCC from the APC/C49,
making it unlikely that cyclin A2 would replace this ABBA motif.
The KEN-box binding site on Cdc20M is buried at the BubR1,
Cdc20, Mad2 interface of the MCC22,23,50 (Fig. 7a, b). Mutating the
first KEN box (K1) of BubR1 that interacts with Cdc20M completely
abolished formation of the MCC49,51. On the other hand, the KEN-
box binding site on Cdc20A is more accessible and has the potential
to accommodate the KEN box of cyclin A2. Cyclin A2 contains a
strong KEN box with the sequence EDQENxxP (Fig. 2g) due to the
Asp and Glu residues at P-1 and P-2 and C-terminal proline resi-
due9. None of the two KEN boxes in BubR1 contains the preferred
acidic residues at P-1 and the C-terminal proline, implying that
cyclin A2 KEN box may have a higher affinity for the binding
pocket, thereby displacing the KEN box (K2) of BubR1.
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We showed that cyclin A2 interacts the D-box binding site of
Cdc20M within APC/CMCC. The D-box binding pocket on
Cdc20M is exposed at the periphery, whereas that on Cdc20A is
deeply buried between Cdc20A and the APC/C22,23 (Fig. 7a, b).
Association of the D2 box of cyclin A2 with Cdc20M would allow
the N-terminus of cyclin A2 to bridge both Cdc20A and Cdc20M
subunits, through its KEN box and ABBA motif, respectively
(Fig. 7a, b). This cyclin A2-mediated bridging of APC/CCdc20
with the MCC may stabilize APC/CMCC and compensate for the
disruption of BubR1 contacts with both Cdc20A and Cdc20M.
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The additional affinity for APC/CMCC provided by the D1 box of
cyclin A2 is likely mediated by avidity effects, providing insights
into the role of multiple copies of the same degron present in
some APC/C substrates. The metaphase substrates cyclin B1,
which lacks both a functional KEN box and an ABBA motif, and
securin, which lacks the ABBA motif and association of the Cks
subunit, are unable to engage APC/CMCC and are thus stabilized
during an active SAC.
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Fig. 7 Mechanism of how cyclin A2 evades the SAC and conversion of cyclin B1 into a prometaphase substrate. a Schematic cartoon showing that Cdk-
cyclinA2-Cks2 associates with APC/CMCC and displaces the ABBA motif (A2) and the D box (D2) of BubR1 from Cdc20M. The more exposed KEN-box
binding site on Cdc20A is likely to accommodate the KEN box of cyclin A2. Binding of cyclin A2 may induce the open state MCC. We propose that the D2
box is the principle D box; however, the D1 box augments affinity through an avidity effect. Bottom: Schematic of BubR1 domain organization showing its
degrons and the respective interacting Cdc20 subunits. b Close-up view of a model with cyclin A2 associating with Cdc20A-MCC (PDB 5LCW22). Cyclin
A2 degrons are shown modelled as surface representations in orange occupying the more exposed degron-binding sites based on the equivalent pseudo-
degrons of BubR122. The remaining three degron-binding sites where BubR1 degrons could still engage are highlighted as red spheres (A1, D1, K1). c, d
Insertion of both the KEN box and ABBA motif into cyclin B1 allowed it to resist MCC-imposed inhibition (compare lanes 1, 2 and 9, 10). Cyclin B1 is in
complex with Cdk2-Cks2. The histogram of relative APC/CMCC activity is normalized to respective APC/CCdc20 activity, with error bars indicating
standard deviation, and significance is calculated using unpaired Student’s t-test (indicated with stars, n= 2, Supplementary Table 2). Source data are
provided as a Source Data file
Fig. 6 Cdk2-cyclinA2-Cks2 associates with APC/CMCC, with its ABBA motif and D2 box binding to Cdc20M. a–d Size exclusion chromatography showed
formation of a stable APC/CMCC-Cdk2-cyclinA2-Cks2 complex with a peak shifted to higher molecular weight (blue line) compared to either APC/CMCC
(purple line) or Cdk2-cyclinA2-Cks2 alone (red line). Cdk2-cyclinA2-Cks2 was added at a molar ratio of 33:1 to APC/CMCC, where it could efficiently resist
MCC-mediated inhibition in the ubiquitination assays. The fractions of APC/CMCC-Cdk2-cyclinA2-Cks2 (b), APC/CMCC alone (c) and Cdk2-cyclinA2-
Cks2 alone (d) were analysed on SDS-PAGE. e, f Disruption of the ABBA-motif-binding pocket on Cdc20 (with point mutations I235S&Y279E) of the MCC
(Cdc20M) strongly reduced the resistance of cyclin A2 to MCC-imposed inhibition of APC/C activity (lanes 7–9), whereas the same mutation on Cdc20A
had no effect (lanes 4–6). g, h Disruption of the hydrophobic interactions within the D-box binding site (L176A) on Cdc20M resulted in increased inhibition
of cyclin A2 ubiquitination by APC/CMCC (lanes 7–9). The histogram of relative APC/CMCC activity is normalized to respective APC/CCdc20 activity, with
error bars indicating standard deviation, and significance is calculated using unpaired Student’s t-test (indicated with stars, n= 2 for f and h, Supplementary
Table 2). Source data are provided as a Source Data file
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Surprisingly, cyclin A2 associates with APC/CCdc20 through
two distinct binding modes; a high activity mode mediated by its
KEN and D2 boxes (Fig. 4i), and a lower activity mode via its
KEN and D1 boxes and ABBA motif (Fig. 4j). Differences in the
accessibility of lysines to the catalytic module between these two
modes, or the distinct conformational states of Cdc20WD40, may
account for the different efficiency of cyclin A2 ubiquitination
associated with these two binding modes. Our findings reveal that
a single substrate can engage the APC/C through multiple
binding modes to influence its timing and efficiency of ubiqui-
tination. In principle, controlling which binding mode is adopted,
possibly by restricting access to either the D1 or D2 box, would
regulate the rate of cyclin A2 ubiquitination.
Methods
Expression and purification of human APC/C, MCC and coactivators. The
genes for recombinant human APC/C were cloned into a modified MultiBac sys-
tem, expressed and purified as described52. The C-terminus of Apc4 was fused to a
TEV (tobacco etch virus)-cleavable StrepIIx2 tag. In brief, recombinant APC/C
expressed in High Five cells are purified with StrepTactin Superflow Cartridges
(Qiagen) and eluted with 2.5 mM desthiobiotin (Santa Cruz). Eluted fractions from
StrepTactin columns were incubated with TEV protease overnight at 4 °C and
subsequently applied onto a 6 ml Resource Q anion-exchange column (GE
Healthcare). Peak fractions after Resource Q were concentrated and further pur-
ified by a Superose 6 10/300 GL column (GE Healthcare).
Human Cdc20, Cdh1 and MCC were expressed and purified as described22,46,48
Full-length human Cdc20 was cloned into a modified FastBac HTa vector with an
N-terminal His-MBP tag and expressed in Sf9 cells. Cdc20 was purified with a
HisTrap HP column (GE Healthcare). Following TEV-cleavage overnight, the
protein was re-applied onto the HisTrap HP column and the flow-through was
collected. Full-length human Cdh1 contains an N-terminal His-tag and was
expressed in High Five cells. Cdh1 was purified using the same procedure as Cdc20
except for an additional final purification step with the Superdex200 16/60 column
(GE Healthcare). MCC was purified using a similar procedure as the APC/C with a
StrepTactin Superflow cartridge (Qiagen) and a Superose 6 10/300 GL column (GE
Healthcare).
Mutations in the degron-binding pockets of Cdc20 were introduced by site-
directed mutagenesis. Two ABBA-motif-binding site mutants Cdc20I235S&Y279E
and Cdc20I235S&V295K were generated. Two D-box binding pocket mutants were
generated, with Cdc20D177S&E465S disrupting the Arg-binding site and Cdc20L176A
disrupting the hydrophobic binding pocket. The corresponding MCC mutants
were produced by combining mutated Cdc20 with the wild-type BubR1, Bub3 and
Mad2 proteins.
Cloning, expression and purification of APC/C substrates. Full-length human
cyclin A2 and cyclin B1 were cloned into a pETM41 vector with an N-terminal His-
MBP tag. The protein was expressed in either BL21 (DE3) Star cells for cyclin A2
or B834 (DE3) pLysS cells for cyclin B1 at 18 °C overnight. Full-length human
cyclin B1 additionally was cloned into a FastBac HTa vector using restriction
enzyme cloning (NcoI and NotI) and expressed in Sf9 cells. Cdk2 phosphorylated
at T160 was produced in E. coli by coexpression of human GST–CDK2 and S.
cerevisiae GST–Cak1 (Cak1 is also called Civ1) as described53 and D. Barford, J.
Tucker, N.R. Brown and N. Hanlon (unpublished data). Pellets containing GST-3C-
Cdk2, His-MBP-TEV-cyclin A2 or cyclin B1 and His-SUMO-TEV-Cks2 were co-
lysed in the CDK lysis buffer (50mM Tris/HCl pH 8.0, 200mM NaCl, 5% glycerol
and 2mM DTT) supplemented with 0.1mM PMSF, lysozyme, 5 units ml−1 ben-
zonase and CompleteTM EDTA-free protease inhibitors (Roche). After sonication, the
cells were centrifuged at 48,000 × g for 1 h at 4 °C and the supernatant was incubated
with the Glutathione SepharoseTM 4B (GE Healthcare) for 3 h at 4 °C. The resin was
washed with the CDK lysis buffer and the GST-tag of Cdk2 was cleaved off with 3C
PreScission protease overnight at 4 °C. The flow-through from the resin was collected
and TEV-cleaved overnight at 4 °C. Finally, the protein complex was purified by a
Superdex 200 16/60 column (GE Healthcare) in the gel filtration buffer (20mM
Hepes pH 8.0, 150mM NaCl, 0.5mM TCEP).
The cyclin A2ΔK mutant has the sequence DQEN replaced with Ala, while for
the cyclin A2ΔD1 mutant the consensus residues at positions 1, 4 and 7 were
mutated to Ala. For the cyclin A2ΔABBA mutant, the entire ABBA motif
(PAFTIHVDE) was mutated to Ala. The cyclin A2D2mut2 has the D2 box
(VAPLKDL) mutated to AAPAKDA. The cyclin B1Δ’K’ mutant has the sequence
NAEN replaced with Ala, whereas it was mutated to DQEN for the cyclin A2 KEN
box insertion. A GSA-linker was inserted to match the amino acid distance
between the KEN box and the D2 box in cyclin A2. The ABBA motif was inserted
in cyclin B1 at the same amino acid distance as the D2 box and the ABBA motif in
cyclin A2.
Full-length human securin was tagged with an N-terminal GST-tag and was
expressed in BL21 (DE3) Star cells at 18 °C overnight. The cell pellets were lysed in
CDK lysis buffer, following sonication the cleared lysate was incubated with the
Glutathione SepharoseTM 4B (GE Healthcare) for 3 h at 4 °C. The resin was washed
with the CDK lysis buffer and the GST-tag of securin was cleaved off with 3C
PreScission protease overnight at 4 °C. The flow-through from the resins was
collected and applied on a 6 ml Resource Q column (QIAGEN) to remove
contaminants before purification by size exclusion chromatography using a
Superdex 75 16/60 column (GE Healthcare) in the gel filtration buffer.
The securinΔD box mutant has the consensus residues at positions 1, 4 and 7
mutated to Ala, while the securinD2 mutant has the entire native D box replaced
with residues 60–80 of cyclin A2.
APC/C complex formation. Purified APC/CΔApc1-300s (lacking Apc1 residues
307–395)48 was incubated with purified Cdc20 and Cdk2-cyclinA2-Cks2 (either
wild-type or mutant) at a molar ratio of 1:1.5:3 on ice before being purified on a
Superose 6 10/300 column (GE Healthcare). The APC/C-substrate complexes were
crosslinked with a water soluble crosslinker BS3 (bis[sulfosuccinimidyl] suberate)
(Thermo Scientific). Crosslinking conditions were optimized across a range of
temperature, crosslinker concentration and reaction time and assessed by 4–12%
NuPAGE Bis-Tris gels as well as 4–16% NativePAGE Bis-Tris gels (Thermo
Fischer). The optimal conditions for APC/C complexes were found to be at 1 mM
BS3 on ice for 30 min. The crosslinking reaction was quenched by addition of
50 mM Tris-HCl pH 8.0 and incubation on ice for 30 min. Crosslinked APC/C
complexes were purified by a Superose 6 Increase 3.2/300 column (GE Healthcare)
using the Microakta system (GE Healthcare).
To prepare the complex APC/CMCC-Cdk2-cyclinA2-Cks2, the APC/C was first
phosphorylated by the kinases Cdk2-cyclinA2-Cks2 (truncated version without the
N-terminal degrons of cyclin A2 (residues 174–432, lacking any degrons in cyclin
A2)) and Plk1 (described in48). This was then purified on a 1 ml Resource Q
column (QIAGEN) to remove kinases and ATP before addition of a 2x molar ratio
of purified MCC. The APC/CMCC complex was purified on a Superose 6 10/300
column in the gel filtration buffer. Purified APC/CMCC was mixed with Cdk2-
cyclinA2-Cks2 at a molar ratio of 1:33 and applied to a Superose 6 Increase 3.2/300
column to remove excess substrates and then used for grid preparation for cryo-
EM.
Binding assay of Cdk2-cyclinA2-Cks2 to APC/CMCC. Pre-formed and purified
APC/CMCC complex at 1 mgml−1 was mixed with 33 times excess (molar ratio) of
either wild-type Cdk2-cyclinA2-Cks2 or Cdk2-cyclinA2ΔABBA-Cks2 and incubated
on ice for 15 min. The mixture was purified on a Superose 6 Increase 3.2/300
column using the Microakta system (GE Healthcare) and the eluted peak fractions
were analysed by SDS-PAGE on 4–12% NuPAGE Bis-Tris gels. Control runs of
APC/CMCC alone and Cdk2-cyclinA2-Cks2 alone were performed with the same
conditions.
Cyclin A2 ABBA peptide pull-down assays. Biotinylated cyclin A2 ABBA peptide
(Designer BioScience) with the sequence GGANSKQPAFTIHVDEAE was dis-
solved in the gel filtration buffer to a concentration of 1 mM. The ABBA peptide
was mixed with purified wild-type Cdc20, Cdc20I235S&Y279E and Cdc20I235S&V295K
and incubated with 50 μl StrepTactin beads (QIAGEN) at 4 °C for 2 h in an
eppendorf tube. The mixture was centrifuged at 2800 × g for 2 min at 4 °C in a
tabletop centrifuge (Eppendorf Centrifuge 5418 R) to remove unbound proteins (in
the supernatant) and washed three times with the gel filtration buffer before eluting
with 50 μl 1x SDS-PAGE dye and boiling at 98 °C for 5 min. The boiled mixture
was centrifuged for 1 min and the supernatant (elution) was carefully removed.
Individual samples were loaded onto a 4–12% NuPAGE Bis-Tris SDS-PAGE gel for
analysis.
Ubiquitination assays. The ubiquitination assay was performed with 60 nM
recombinant human APC/C (for Cdh1) or phosphorylated APC/C (for Cdc20) or
APC/CMCC, 90 nM UBA1, 300 nM UbcH10, 300 nM Ube2S, 70 µM ubiquitin,
2 µM substrates (or titration of concentration), 5 mM ATP, 0.25 mgml−1 BSA,
15 µM CDK1/2 inhibitor iii (Enzo Life Sciences) and 30 nM Cdc20 or Cdh1 in a
10 µl reaction volume with 40 mM Hepes pH 8.0, 10 mM MgCl2 and 0.6 mM DTT.
The intracellular concentration of APC/C is reported as 80 nM38, and that of
Cdc20 is 100 nM37,38, BubR1 90–130 nM and Mad2 (120 nM)38, also references
within ref. 54. Cdk2 was estimated at 120–350 nM, whereas cyclin A2 and cyclin B1
were estimated at ~10–13 nM39.
Reaction mixtures were incubated at room temperature for 30 min or various
time points and terminated by adding SDS/PAGE loading dye. Cdk2 activity was
inhibited by addition of 15 µM CDK1/2 inhibitor iii (Enzo Life Sciences), thereby
preventing APC/C, coactivator, MCC and substrate phosphorylation. In the
absence of the Cdk1/2 inhibitor the activity of APC/CCdc20 was greatly reduced
(Supplementary Fig. 1a). Reactions were analysed by 4–12% NuPAGE Bis-Tris gels
followed by western blotting with an antibody against the His-tag of ubiquitin to
detect the His-tag of the ubiquitin-modified substrates (Clonetech, mouse
monoclonal, 631212) and HRP-conjugated sheep anti-mouse antibody (GE
Healthcare, NXA931V). Control gels showing the unmodified substrate for
representative reactions are shown in Supplementary Fig. 2. Detection of cyclin A2
was performed with the rabbit monoclonal cyclin A2 antibody (Abcam, ab32386),
detection of cyclin B1 with the rabbit monoclonal cyclin B1 antibody (Abcam,
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ab32053), detection of securin with the rabbit monoclonal securin antibody
(Invitrogen, 700791), detection of Apc4 with the rabbit monoclonal Apc4 antibody
(Abcam, ab72149) and HRP-conjugated donkey anti-rabbit antibody (Thermo
Fischer, SA1-200). Primary antibodies were used at a dilution of 1:1000 and
secondary antibodies at a dilution of 1:5000.
The following peptides (Designer BioScience) were used in the ubiquitination
assays: cyclin A2 6080 peptide (GLAQQQRPKTRRVAPLKDLPV) and Hsl1 D box
peptide (SKRAALSDITNSSD). The peptides were dissolved at a concentration of
10 mM in the gel filtration buffer.
Tissue culture and generation of stable cell lines. HEK293 FlpIn-TRex cells
(Invitrogen, cat. Number R78007) were cultured in DMEM (Gibco) supplemented
with 10% tetracycline free FBS (PAN Biotech) at 37 °C and 5% CO2.
For the stable integration of eGFP-cyclin A2 into the genome, all variants were
cloned into the pcDNA5-FRT-TO vector (Invitrogen) with an N-terminal eGFP
tag. HEK293 FlpIn-TREX cells were transfected with the pcDNA5-FRT-TO
plasmids and pOG44, containing the flippase, using the HBS method. In short,
cells were seeded the evening before transfection and the medium was exchanged
the next morning. Both plasmids were mixed with 160 mM CaCl2 and 2x
HBS buffer (final concentrations: 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4,
7.5 mM D-Glucose, 21 mM HEPES) and added to the cells. The subsequent
steps were performed according to the Invitrogen manual. Cells were selected using
100 ug mL−1 Hygromycin B gold (InVivoGen). All stable cell lines were always
kept under selection. Cyclin A2 detection in western blot was performed with the
rabbit monoclonal cyclin A2 antibody (Abcam, ab32386).
Live cell microscopy. At a density of 75,000 cells per well, cells were seeded in an
eight-well glass bottom microscopy slide (Ibidi) pre-coated with poly-L-lysine
(Sigma) the evening before the experiment. To induce the expression of the eGFP-
cyclin A2 variants, 0.25 ng mL−1 doxycycline (Sigma) was added and the cells were
synchronized in S-phase by the addition of 1 mM thymidine (Sigma). The next
morning cells were released from thymidine by washing five times with fresh
medium, while doxycycline was kept present. After 4–5 h, the medium was
changed to CO2-independent medium (Gibco) supplemented with 10% tetra-
cycline free FBS (PAN Biotech) and GlutaMax (Gibco). The medium also con-
tained 500 nM SiR-DNA (Chromotek) to visualise the DNA during live cell
imaging and in some cases S-trityl-L-cysteine (STLC, Sigma) to induce a SAC
arrest. After 1 hour of incubation the imaging was started using a SP8 confocal
microscope (Leica) equipped with a heated environmental chamber, an argon laser,
a 630 nm laser line and a ×40/1.1 numerical aperture water immersion lens. Two Z-
stacks were defined with 5 µm spacing and the imaging was performed for 6 h (in
the case of the SAC videos) or 14 h (in case of unperturbed mitosis). For the SAC
videos the imaging was paused and a final concentration of 500 nM reversine
(Sigma) was added to the cells. The positions were adjusted in their Z-stack to
compensate for the additional medium (which took around 10 min) and the
imaging was continued for one additional hour.
Quantification of ubiquitination assay and fluorescence images. Quantification
of the ubiquitination assays were performed in ImageJ and plotted using Prism 8
(Graphpad). Fluorescence intensity of cells was measured using ImageJ (NIH) as
described in ref. 55, with the exception that only a smaller circle inside the cell was
chosen to measure the fluorescence intensity. It was ensured that the circle was
always inside the cell and represented the overall behaviour of the eGFP signal. If
this was not achievable the circle was adjusted or moved and the measurement of
the effected time points was repeated. Data analysis and calculation of the eGFP-
cyclin A2 degradation rate were performed using Excel (Microsoft) and graphs
were created with Prism 7 and Prism 8 (Graphpad).
A two tailed Student’s t-test was used to calculate the significance, except for
data represented in Supplementary Fig. 3b, d, e, where a simple ANOVA test
followed by Dunnett’s multiple comparison test was used. One star indicates
significance smaller than 0.05, two stars indicate significance smaller than 0.01,
three and four stars indicate significance smaller than 0.001 and 0.0001
respectively. Statistical analysis was performed with Prism 8 (Graphpad). All
experiments were repeated at least two times and all measurements were taken
from independent samples. All values in the graphs are represented as mean ± s.d.
(standard deviation). The number of cells analysed is given in the corresponding
figure legends. The exact p-values are summarised in Supplementary Table 2.
Cryo-electron microscopy. For cryo-EM, 2 µl aliquots of freshly purified APC/C
complexes at ~0.15 mgml−1 were applied onto Quantifoil R2/2 grids or R3.5/1
grids coated with a layer of continuous carbon film (~50 Å thick). Grids were
treated with a 9:1 argon:oxygen plasma cleaner (Fischione Instruments Model 1070
Nano clean) for 20–40 s depending on the thickness of the carbon before use. The
grids were incubated for 30 s at 4 °C and 100% humidity before blotting for 5 s and
plunging into liquid ethane using a FEI Vitrobot III. The grids were loaded into a
FEI Tecnai Polara or a FEI Titan Krios electron microscope operating at an
acceleration voltage of 300 kV. Cryo-EM data for APC/CΔApc1-300s in complex with
Cdc20 and wild-type Cdk2-cyclinA2-Cks2 were collected at the Diamond Light
Source on the FEI Titian Krios at a pixel size of 1.047 Å pixel−1 using the Gatan K2
detector in electron counting mode. The rest of the cryo-EM data were collected on
LMB microscopes, either on the FEI Tecnai Polara at a pixel size of 1.06 Å pixel−1
using the FEI Falcon III direct electron detector in integration mode (APC/CMCC-
Cdk2-cyclinA2-Cks2) or on the FEI Titan Krios at a pixel size of 1.1 Å pixel−1
using the Gatan K2 detector in electron counting mode (APC/CΔApc1-300s-Cdc20-
Cdk2-cyclinA2ΔABBA-Cks2 and APC/CMCC). Micrographs were recorded with a
defocus range of −2.0 to −4.0 µm in integration mode and a defocus of −0.5 to
−3.0 µm in electron counting mode. The exposure time for each micrograph was
1.2 s at a dose rate of 26 electrons Å−2s−1 for the Falcon III integration mode data
collection and 36 movie frames were recorded for each micrograph, while 7 s
exposure at a dose rate of 5 electrons pixel−1s−1 was used in the K2 electron
counting mode and 28 movie frames were recorded for each micrograph.
Image processing. All movie frames were aligned by motioncor256 program
before subsequent processing. First, the contrast transfer function (CTF) para-
meters were calculated with Gctf57. Particles in 400 × 400 pixels were selected by
automatic particle picking in RELION 3.058. The following steps were performed to
exclude bad particles from the dataset: (1) automatically picked particles in each
micrograph were screened manually to remove ice contaminations59; (2) after
particle sorting in RELION, particles with poor similarity to reference images were
deleted; (3) two-dimensional classification was performed and particles in bad
classes with poorly recognizable features were excluded. The remaining particles
were refined using RELION three-dimensional (3D) refinement and divided into
eight classes using 3D-classification in RELION with fine-angle search. During this
process leftover bad particles were removed. Following three-dimensional-
refinement of all good particles, fine-angle search three-dimensional classification
was performed to separate the APC/C complex in different conformations. Beam-
induced particle motion was corrected using Bayesian polishing in RELION 3.0.
Particle subtraction was performed for the region of interest, either the substrate
recognition site formed by Cdc20WD40 and Apc10 or the MCC, using a soft mask
(initial extension 3, soft edge 6) surrounding the region of interest followed by
focused 3D-classification. Classes with improved coactivator or MCC density were
3D-refined in RELION individually. Multiple rounds of particle subtraction,
focused 3D-classification and 3D-refinement were performed to separate different
conformations. Final maps were sharpened and filtered in RELION Post-
processing. Local resolution of the maps was estimated using RELION. All reso-
lution estimations were based on the gold-standard Fourier Shell Correlation (FSC)
calculations using the FSC= 0.143 criterion. A summary of all EM reconstructions
obtained in this paper is listed in the Supplementary Table 1.
Map visualization. Figures were generated using Pymol (The PyMOL Molecular
Graphics System, Version 2.0 Schrödinger, LLC.) and Chimera60.
Sequence alignment. Sequence alignment was performed using Jalview61.
Data availability
EM maps are deposited in the Electron Microscopy Data Bank under accession codes:
4463 (APC/CMCC-Cdk2-cyclinA2-Cks2 open conformation) [https://www.ebi.ac.uk/
pdbe/entry/emdb/EMD-4463], 4464 (APC/CMCC-Cdk2-cyclinA2-Cks2 closed
conformation) [https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-4464], 4465 (APC/
CΔApc1-300s-Cdc20-Cdk2-cyclinA2-Cks2 D1 class) [https://www.ebi.ac.uk/pdbe/entry/
emdb/EMD-4465], 4466 (APC/CΔApc1-300s-Cdc20-Cdk2-cyclinA2-Cks2 D2 class)
[https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-4466], and 4467 (APC/CΔApc1-300s-
Cdc20-Cdk2-cyclinA2ΔD1-Cks2) [https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-4467].
Protein coordinates are deposited in the Protein Data Bank under accession codes: 6Q6G
(APC/CΔApc1-300s-Cdc20-Cdk2-cyclinA2-Cks2 D1 class) and 6Q6H (APC/CΔApc1-300s-
Cdc20-Cdk2-cyclinA2-Cks2 D2 class). The source data underlying Figs. 1b, d, f, 2a, b, e,
3a, b, d, e, 4k, 5a, c, 6b–d, e and g and Supplementary Figs. 1a–g, i, j, 2, 4a, d, 6a, d–f and
6h are provided as a Source Data file. Cell lines that were generated for and used in this
study are available upon request from the authors.
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